Exponent, Inc. (EXPO) Holdings Trimmed by MetLife Investment Advisors LLC

MetLife Investment Advisors LLC lessened its stake in shares of Exponent, Inc. (NASDAQ:EXPO) by 39.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 21,852 shares of the business services provider’s stock after selling 14,334 shares during the period. MetLife Investment Advisors LLC’s holdings in Exponent were worth $1,108,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of EXPO. BlackRock Inc. boosted its position in Exponent by 0.3% during the fourth quarter. BlackRock Inc. now owns 7,502,036 shares of the business services provider’s stock worth $380,427,000 after purchasing an additional 20,319 shares during the period. Vanguard Group Inc boosted its position in Exponent by 2.8% during the third quarter. Vanguard Group Inc now owns 5,147,145 shares of the business services provider’s stock worth $275,887,000 after purchasing an additional 139,183 shares during the period. Vanguard Group Inc. boosted its position in Exponent by 2.8% during the third quarter. Vanguard Group Inc. now owns 5,147,145 shares of the business services provider’s stock worth $275,887,000 after purchasing an additional 139,183 shares during the period. Conestoga Capital Advisors LLC boosted its position in shares of Exponent by 2.6% in the fourth quarter. Conestoga Capital Advisors LLC now owns 2,310,721 shares of the business services provider’s stock valued at $117,177,000 after acquiring an additional 57,955 shares during the period. Finally, Bank of New York Mellon Corp boosted its position in shares of Exponent by 2.7% in the third quarter. Bank of New York Mellon Corp now owns 779,747 shares of the business services provider’s stock valued at $41,794,000 after acquiring an additional 20,703 shares during the period. Institutional investors and hedge funds own 90.18% of the company’s stock.

A number of research firms have recently commented on EXPO. Zacks Investment Research upgraded shares of Exponent from a “hold” rating to a “strong-buy” rating and set a $64.00 price objective for the company in a research report on Tuesday. BidaskClub raised shares of Exponent from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, March 27th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and issued a $56.00 target price on shares of Exponent in a research note on Tuesday, January 15th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $61.33.

In related news, insider Harri Kytomaa sold 2,366 shares of Exponent stock in a transaction on Friday, February 22nd. The shares were sold at an average price of $56.27, for a total value of $133,134.82. Following the sale, the insider now owns 3,816 shares in the company, valued at $214,726.32. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 2.30% of the company’s stock.

EXPO stock opened at $56.64 on Friday. The company has a market cap of $2.91 billion, a price-to-earnings ratio of 45.31 and a beta of 0.47. Exponent, Inc. has a one year low of $42.58 and a one year high of $59.80. The company has a current ratio of 4.22, a quick ratio of 3.32 and a debt-to-equity ratio of 0.06.

Exponent (NASDAQ:EXPO) last issued its earnings results on Thursday, April 18th. The business services provider reported $0.42 EPS for the quarter, topping the consensus estimate of $0.35 by $0.07. Exponent had a net margin of 19.53% and a return on equity of 23.10%. The company had revenue of $93.40 million for the quarter, compared to the consensus estimate of $93.52 million. During the same period in the previous year, the firm earned $0.75 earnings per share. The firm’s revenue for the quarter was up 3.0% on a year-over-year basis. On average, analysts anticipate that Exponent, Inc. will post 1.42 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, June 21st. Investors of record on Friday, June 7th will be issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 1.13%. The ex-dividend date of this dividend is Thursday, June 6th. Exponent’s dividend payout ratio (DPR) is currently 51.20%.

TRADEMARK VIOLATION WARNING: “Exponent, Inc. (EXPO) Holdings Trimmed by MetLife Investment Advisors LLC” was first published by Baseball Daily News and is owned by of Baseball Daily News. If you are reading this story on another website, it was illegally stolen and reposted in violation of US and international copyright legislation. The correct version of this story can be accessed at https://www.baseballdailydigest.com/news/2019/04/27/exponent-inc-expo-stake-decreased-by-metlife-investment-advisors-llc.html.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.

Recommended Story: What impact do institutional investors have on markets?

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.